儿童颅咽管瘤质子放疗后白质脑龄纵向变化
本研究基于90例接受54-Gy质子放疗的儿童颅咽管瘤患者扩散加权成像数据,开发并验证了以主要白质纤维束各向异性分数为基础的岭回归脑龄模型。纵向分析显示,治疗后5年脑龄差为-2.78岁,脑龄差随时间显著下降,且存在时间-年龄与时间-性别交互作用。
要点
- 儿童颅咽管瘤患者放疗后白质脑龄差随时间呈负向增大,提示白质成熟延迟。
- 基线年龄较小者及男性患者脑龄差下降更明显,随访阅片应关注白质发育轨迹。
- 该脑龄模型基于常规DWI数据,平均绝对误差约2年,可作为神经发育完整性定量参考。
核心结论
- 儿童颅咽管瘤患者接受质子放疗后表现为相对基线状态的脑龄延迟,脑龄差随时间显著下降。
- 时间与年龄、时间与性别存在显著交互作用,提示年龄和性别影响脑龄差的纵向变化。
- 基线的年龄和IGF-1 z评分与脑龄差变化呈正相关。
研究设计与样本
- 研究类型为回顾性分析,纳入90例接受54-Gy质子放疗并完成5年随访的儿童颅咽管瘤患者。
- 使用扩散加权成像采集数据,从主要白质纤维束获得各向异性分数构建岭回归脑龄模型。
- 模型训练集72例,独立测试集18例,评估时间点为放疗前术后基线及随后5年每年随访。
- 参考标准为同队列患者的实际年龄,模型以平均绝对误差和均方根误差评价脑龄预测性能。
关键影像表现/征象
- 脑龄模型基于主要白质纤维束的各向异性分数,反映白质微结构完整性而非常规肉眼可见征象。
诊断标准与关键数值
- 岭回归模型在训练集平均绝对误差为1.88年,均方根误差为2.42年。
- 岭回归模型在独立测试集平均绝对误差为2.00年,均方根误差为2.57年。
- 基线中位脑龄差为0.01年,5年后中位脑龄差为-2.78年。
- 线性混合效应回归中时间与脑龄差呈显著负相关,βTime[95% CI] = -0.25[-0.41至-0.09],P < .001。
- 时间-年龄交互项βTime:Age[95% CI] = -0.24[-0.34至-0.13],P < .001;时间-性别交互项βTime:Sex[Male][95% CI] = -0.23[-0.42至-0.05],P = 0.016。
临床应用与阅片要点
- 基于扩散加权成像各向异性分数的脑龄模型可作为儿童颅咽管瘤治疗后白质成熟的定量随访工具。
- 随访中脑龄差负值增大提示白质发育延迟,阅片时可结合脑龄差变化辅助判断神经发育完整性。
- 年龄较小和男性患者脑龄差随时间下降更明显,解读随访结果时应考虑年龄和性别差异。
局限性
- 本研究为单中心回顾性分析,样本量为90例儿童颅咽管瘤患者。
- 脑龄模型平均绝对误差约2年,预测精度存在一定局限。
- 原文指出未来需进一步评估导致颅咽管瘤相关成熟障碍的致病因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Brain tumors and subsequent tumor-directed treatments including surgery, radiotherapy, and chemotherapy may disrupt brain maturation in children, but there are limited quantitative methods to assess this outcome beyond the behavioral and mental constructs of cognitive testing. Here, we developed a brain age estimation tool that uses standard clinical imaging to measure changes in neurodevelopmental integrity after cranial radiotherapy.
METHODS: Diffusion-weighted imaging data were collected from 90 pediatric patients with craniopharyngioma who received 54-Gy proton radiotherapy and completed a 5-year follow up regimen. In this retrospective analysis, a ridge regression model was developed from fractional anisotropy scores obtained from major white-matter tracts. Model accuracy was validated on an independent test set. Training and testing samples included data from 72 and 18 patients, respectively. The brain age and age-adjusted brain age gap from this validated model were then calculated at 6 timepoints: at post-operative baseline before radiotherapy and during each of the 5 annual follow-up visits. Longitudinal changes in brain age gap were evaluated by multivariable linear mixed-effects analysis to identify possible predictors of brain age gap change.
RESULTS: The median participant age was 9.17 [1.85 to 20.1] years at baseline. Forty-nine participants (54%) were female. The ridge regression model performed strongly on both training datasets (mean absolute error = 1.88 years; root mean square error = 2.42 years) and test datasets (mean absolute error = 2.00 years; root mean square error = 2.57 years). The median brain age gap was 0.01 years at baseline and -2.78 years after 5 years. The brain age gap was negatively associated with time in the linear mixed-effects regression (βTime [95% CI] = -0.25 [-0.41 to -0.09], P < .001), with a significant time-by-age interaction (βTime:Age [95% CI] = -0.24 [-0.34 to -0.13], P < .001) and time-by-sex interaction (βTime:Sex[Male] [95% CI] = -0.23 [-0.42 to -0.05], P = 0.016) interactions. Age and baseline IGF-1 z-scores were positively correlated with brain age gap (β [95% CI] = 0.27 [0.03-0.51], P = 0.027).
CONCLUSIONS: We used diffusion-weighted imaging data to model brain age in children treated for craniopharyngioma. Our findings suggest that patients treated for craniopharyngioma demonstrate delayed brain aging compared to their baseline status. Future work will evaluate causative factors for craniopharyngioma-related maturation disruptions.
引用
- VanGilder, Arif, Hooyman, et al. Evaluating alterations in longitudinal white matter brain age in survivors of pediatric craniopharyngioma. AJNR Am J Neuroradiol. 2026. PMID: 42431714. doi:10.3174/ajnr.A9521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。